Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP7147 in IBS-D
NCT01896583Phase 2Completed
- Sponsor
- Seldar Pharma
- Start
- Nov 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP7147 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Seldar Pharma. Started Nov 2013; status: completed.
02
Drugs
ASP7147
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01896583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896583.